The 'Week in Review' - 25 November

This week, we mark a significant anniversary, discuss the risks of missing the opportunity that artificial intelligence offers to speed access to healthcare, and explore why some might be reluctant to...

11 Syys 59min

This week's discussion starts with the perfect example of why pulling one lever can trigger another. The Senate's considering changes to expand the regulator's power, without any submissions from thos...

4 Syys 54min

Why pulling the same 'levers' on reform cannot work. Comparing one medicines access program and its humanitarian underpinnings to our institutional frameworks. The need for term limits on advisory com...

28 Elo 1h 6min

The opportunities available in the pending negotiation of new industry agreements and the selective discrimination against some patients and patient groups by an outdated and unaccountable institution...

21 Elo 59min

For more than a decade, Public Summary Documents have been presented as evidence of system transparency, but in fact, they are an affront to it. What was the discussion about transparency that ended w...

16 Elo 46min

An important reminder about the impact of innovation and why it matters. What does it say about Australia and our life sciences policy frameworks that locally developed innovations are commercialised ...

7 Elo 33min

The events in the US this week surrounding a former public health leader raise some important questions in Australia about the accountability of 'independent experts'. Why we can't afford to muck up t...

31 Heinä 1h 1min

Misleading claims about patient groups and the industry, combined with an irrational hyperventilation about a rational response to new global realities, have made for an interesting week. The price re...

24 Heinä 53min